# Noninferiority Trial Of Sirolimus With Ascorbic Acid Versus Everolimus in All-comers

> **NCT07566091** · NA · NOT_YET_RECRUITING · sponsor: **Jung-min Ahn** · enrollment: 2034 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Sirolimus-Ascorbic Acid Eluting Stent
- **DEVICE:** Everolimus-Eluting Stent

## Key facts

- **NCT ID:** NCT07566091
- **Lead sponsor:** Jung-min Ahn
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-15
- **Primary completion:** 2027-06-15
- **Final completion:** 2028-06-15
- **Target enrollment:** 2034 (ESTIMATED)
- **Last updated:** 2026-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07566091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07566091, "Noninferiority Trial Of Sirolimus With Ascorbic Acid Versus Everolimus in All-comers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07566091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*